The 2026 National Digital Health Strategy

The National Digital Health Strategy functions as a 10-year roadmap, guiding the sector through 2032. By 2026, the strategy has pivoted to emphasise Medicine 3.0 principles, focusing on preventative, personalised, and proactive care. This approach treats data as a clinical asset, moving beyond simple digitisation to sophisticated data orchestration. Policy updates in 2026 have specifically targeted the integration of aged care and mental health services into the national digital backbone. These sectors previously lagged in digital maturity, but new mandates ensure that a patient's mental health history and aged care requirements are visible to emergency clinicians in real time. The strategy aims for specific, measurable outcomes by 2030, including: Founders building the future of healthcare must align their product roadmaps with these objectives. The government is no longer just a regulator; it's a platform provider. If your solution doesn't facilitate interoperability or contribute to these national KPIs, you'll face significant barriers to entry within the public procurement ecosystem. This policy environment creates a generational investment theme hiding in plain sight for those who understand the regulatory pathways.

The Role of the Australian Digital Health Agency

The Australian Digital Health Agency (ADHA) acts as the operational arm of this transformation, enforcing the technical standards that underpin the entire ecosystem. Its governance of the My Health Record system has evolved from a static document repository into a dynamic data platform. The ADHA now sets rigorous technical requirements for software developers, ensuring that any new healthtech application can communicate with the national infrastructure via standardised APIs. This move has drastically reduced the "walled garden" effect that previously hindered innovation. The agency's current mandate includes: For an operator, the ADHA represents both a gatekeeper and an enabler. Adhering to their standards is not optional for those seeking national scale. By 2026, the agency has streamlined the certification process, allowing capital-efficient startups to validate their security and interoperability credentials more quickly. This regulatory clarity allows you to focus on solving clinical problems rather than fighting infrastructure hurdles. Understanding the digital health policy australia landscape is the first step in building a defensible position in this specialist market. Data silos are the primary friction point in healthtech. For decades, Australian healthcare data remained locked in proprietary formats, creating a fragmented ecosystem that stifled innovation and frustrated clinicians. The current digital health policy australia focuses on dismantling these silos through two specific levers: technical standards and legislative mandates. This shift moves the industry from data hoarding to data liquidity, where information follows the patient rather than staying trapped within a single clinic server.

Understanding FHIR and Sparked

FHIR (Fast Healthcare Interoperability Resources) is the global standard for exchanging electronic health information. It uses a modern, API-first approach that allows startups to query specific data points rather than downloading entire, bloated documents. In late 2023, the Australian government launched Sparked, a national FHIR accelerator. This initiative brings together CSIRO, HL7 Australia and the Department of Health and Aged Care to create a common language for clinical data. For founders, Sparked reduces technical friction by providing clear implementation guides. It ensures your software can communicate with a hospital EMR or a specialist booking system without expensive, one-off integrations. Standardised data is the essential fuel for AI-first product engineering. If your data isn't structured via FHIR, your models will spend 80% of their compute on cleaning rather than inferencing. Dreamoro tracks 1,005 healthtech companies in our proprietary mapping; the most capital-efficient among them are those building on top of these standardised rails from day one. This structural advantage allows for faster scaling across different clinical settings because the integration path is already paved. The shift toward API-first infrastructure means your product becomes a plug-and-play component of the broader health ecosystem rather than a standalone island.

Data Privacy and the Privacy Act

Security is the non-negotiable floor for healthtech. Compliance with the 13 Australian Privacy Principles (APPs) is the baseline, but the regulatory environment is tightening. The Australian government has flagged significant updates to the Privacy Act scheduled for 2026. These updates will likely include more stringent data breach notification requirements and higher penalties for non-compliance. Founders must move beyond simple encryption. You need a decentralised approach to consent management where patients have granular control over who accesses their records. This is particularly vital as digital health policy australia moves toward more integrated, cross-provider care models. Managing consent in a decentralised environment requires a robust identity framework. It's no longer just about protecting data; it's about enabling its safe, authorised movement across the entire value chain. Software vendors who fail to adopt these standards risk being phased out of government procurement cycles and losing trust with clinicians. If you're building the future of healthcare, your technical architecture must anticipate these mandatory sharing requirements. This proactive approach to compliance and interoperability isn't just a regulatory hurdle; it's a defensible strategic advantage that positions your company for long-term growth in a connected health economy. The boundary between a lifestyle tracker and a regulated medical tool is defined by intended use. If your software diagnoses, prevents, monitors, or treats a disease, it likely falls under the jurisdiction of the Therapeutic Goods Administration (TGA). This distinction is the most critical hurdle in your commercialisation journey. Misclassifying your product early leads to significant technical debt and regulatory friction that can stall a Series A round or halt a market launch entirely. Australia's regulatory environment changed significantly on 25 February 2021 when the TGA implemented new requirements for Software as a Medical Device (SaMD). These reforms aligned the digital health policy australia framework with international standards, specifically the International Medical Device Regulators Forum (IMDRF). This alignment ensures that software validated in Australia has a clearer pathway to European and North American markets; however, it also raised the bar for technical documentation and clinical oversight.

Classifying Your Healthtech Product

Your classification dictates your regulatory burden and your capital requirements. Class I software covers low-risk tools, such as simple symptom checkers that don't provide definitive diagnoses. Class IIa and IIb are for moderate-risk applications, including software that provides information used to make diagnostic or treatment decisions. Class III is reserved for high-risk software, such as tools used for life-sustaining functions or diagnosing terminal conditions. Data from 2023 suggests that 65% of new healthtech entries in the Australian market fall into the Class IIa or IIb categories. Registration is mandatory before you can legally supply SaMD in Australia. If your product uses an algorithm to recommend a specific medication dosage, you're no longer in the realm of wellness; you're operating a medical device. This classification directly impacts your go-to-market strategy by adding a minimum of six to twelve months to your timeline for conformity assessment and inclusion on the Australian Register of Therapeutic Goods (ARTG).

Clinical Evidence and Validation

Clinical validation is more than a regulatory box-ticking exercise. It's the primary driver of your company's valuation. Investors look for an evidence base that proves your software delivers the claimed clinical outcomes. While the TGA accepts various forms of evidence, a 2023 review of successful SaMD applications showed a clear preference for prospective clinical trials and high-quality peer-reviewed data. You must demonstrate that your software is safe and performs as intended in a real-world clinical environment. Aligning your product engineering with these documentation needs from the first line of code is essential. Retrofitting compliance into an existing codebase is three times more expensive than building it in from the start. Your first customers, particularly within the public hospital system, will demand this level of rigour before considering a pilot program. By treating digital health policy australia requirements as a strategic asset rather than a burden, you build a defensible moat around your intellectual property. Successful founders treat digital health policy australia as a product specification rather than a compliance hurdle. Aligning your roadmap with federal priorities ensures your solution addresses the specific pain points the Commonwealth is already funded to solve. This alignment facilitates smoother procurement pathways and opens doors to non-dilutive capital. Government is not just a regulator; it's the largest payer and infrastructure provider in the ecosystem. Ignoring federal signals means building in a vacuum. Your product must deliver on the Quadruple Aim: better health outcomes, lower costs, improved patient experiences, and enhanced provider wellbeing. Government procurement teams use these metrics to evaluate value-for-money. If your platform improves patient outcomes but increases clinician burnout, it won't scale. Focus on interoperability. The 2023 Interoperability Plan outlines how data should move between providers. Following these guidelines ensures your product remains relevant as the ecosystem matures.

Targeting High-Priority Health Areas

The 2024-25 Federal Budget allocated $227 million to establish further Medicare Urgent Care Clinics, signalling a shift toward reducing hospital pressure. For the 2026 budget cycle, the Department of Health and Aged Care is prioritising preventative health technology that manages chronic conditions like Type 2 diabetes and cardiovascular disease before they require acute intervention. Founders should track the Medical Research Future Fund (MRFF) grant cycles. These indicate where the government predicts future market demand. AI-enabled diagnostics and remote patient monitoring are currently receiving significant attention because they support "hospital in the home" models.

Integrating with National Infrastructure

Connecting to the My Health Record system is no longer optional for companies seeking enterprise-level adoption. To become an "on-network" provider, your technical team must implement HL7 FHIR standards and secure a Healthcare Provider Identifier-Organisation (HPI-O). Integrating with Medicare APIs allows for automated billing and real-time eligibility checks, which reduces administrative overhead for clinicians by up to 30%. Security is paramount. You must meet the requirements of the Information Security Registered Assessors Program (IRAP) benchmarks to handle federal health data securely. Being on-network builds immediate trust with primary health networks and state health departments. Leveraging the R&D Tax Incentive provides a 43.5% refundable tax offset for eligible entities with a turnover under $20 million. This is vital for capital-efficient growth. Additionally, design your product for the 7 million Australians living in regional and rural areas. Modern digital health policy australia specifically rewards solutions that bridge the "tyranny of distance" by providing equitable access to specialist care. If your software requires high-bandwidth connections not available in the bush, you're excluding a primary government focus area. Accessibility is a commercial advantage, not just a social goal. Navigating these federal priorities requires a disciplined approach to venture building. By integrating with national systems and solving for high-cost chronic diseases, you position your startup as a strategic partner rather than a vendor. This defensibility is what separates sustainable healthtech companies from fleeting experiments. Build your strategy around the Dreamoro healthtech investment thesis to ensure long-term alignment with the Australian healthcare ecosystem. Regulatory compliance is often viewed by founders as a friction point. At Dreamoro, we view it as a competitive moat. In a sector where 70% of early stage failures are linked to regulatory or clinical misalignment rather than technical flaws, policy readiness becomes a structural advantage. When you align your product architecture with the shifting digital health policy australia framework, you aren't just ticking boxes; you're building a barrier to entry that prevents less disciplined competitors from entering your space. This defensible positioning is what separates speculative software from scalable medical infrastructure. Your ability to meet high standards for data sovereignty and clinical safety early in your lifecycle dictates your long term capital efficiency. Companies that ignore these requirements often face a "regulatory debt" that requires significant capital to resolve during a Series A raise. By the time you seek institutional funding, investors expect a clear pathway through TGA classifications or My Health Record integrations. Founders who front-load this strategy find it easier to secure partnerships with major healthcare providers who cannot risk engaging with non-compliant technology.

The Investment Perspective on Policy

We scrutinise regulatory foresight during our vc due diligence process to ensure your business model is sustainable. We've mapped 1,005 healthtech companies and the most successful ones share a common trait: they treat policy as a design requirement. Capital-efficient founders don't wait for a mandate to implement security standards like IRAP or ISO 27001. They build these into their MVP to ensure their strategic positioning remains defensible as the market matures and government oversight tightens.

Partnering for Commercialisation

The Dreamoro Studio works with founders to build for compliance from day one. We don't believe in "moving fast and breaking things" when patient safety is involved. Instead, we use our ecosystem of clinical and regulatory partners to validate your product against current Australian standards. This proactive approach ensures that when you're ready to scale, your technology is already fit for purpose within the public and private health systems. Contact us to discuss your healthtech go-to-market strategy and how to align your vision with the current regulatory environment. The future of Medicine 3.0 in Australia depends on this alignment. We're moving toward a model of healthcare that's proactive, data-driven, and highly personalised. This shift requires a deep understanding of digital health policy australia, specifically regarding how patient data is shared and protected. The Australian government's focus on the Interoperability Plan 2023-2028 signals a clear direction: the future belongs to integrated platforms that can communicate across the entire value chain. If your technology doesn't support this level of connectivity, it'll likely become obsolete as the system moves toward unified health records. Building the future of healthcare requires more than just code. It requires an understanding of the rules that govern the system. By embracing policy as a core component of your product strategy, you create a more resilient business. This discipline is what attracts high-quality talent and sophisticated investors. It's the difference between a tool and a platform. We back the founders who understand this distinction and are ready to build the next generation of defensible, policy-aligned healthtech. Success in the Australian market requires founders to treat regulatory frameworks as a strategic blueprint rather than a compliance burden. By 2026, the government's focus on mandatory interoperability and data standards will separate legacy systems from high-growth ventures. Mastery of digital health policy australia is the most direct path to building a product that integrates seamlessly into the national healthcare infrastructure. Securing TGA clearance for Software as a Medical Device (SaMD) acts as a critical barrier to entry, protecting your intellectual property while ensuring patient safety and clinical validity. Building a resilient company in this sector demands a specialized partner. Dreamoro is a specialist healthtech venture capital firm and an integrated strategy and product engineering studio. Dreamoro applies a deep understanding of Medicine 3.0 and preventative health to every partnership, ensuring your technical roadmap aligns with federal priorities. Dreamoro has mapped over 1,005 companies to identify the specific gaps where new technology can thrive. You can partner with Dreamoro to scale your venture within the Australian healthtech ecosystem. The transition toward a proactive healthcare system offers a generational opportunity for founders who execute with discipline.

What is the National Digital Health Strategy for 2026?

The National Digital Health Strategy for 2026 focuses on creating a connected, person-centred healthcare system through four key health outcomes. These include ensuring every Australian has a digital health record and improving health data exchange between providers. For founders, this digital health policy australia mandates a shift toward interoperability; the government aim is to have all clinical systems sharing data by 2026 to improve patient safety.

Does my healthtech app need TGA approval in Australia?

Your app requires TGA approval if it meets the definition of a medical device, specifically if it diagnoses, prevents, or treats a disease. While some low-risk apps are exempt under the 2021 regulatory changes, most clinical decision support tools require entry on the Australian Register of Therapeutic Goods. You should consult the TGA boundary guidance to determine your specific classification before starting your go-to-market strategy to avoid regulatory delays.

What are the FHIR standards and why do they matter for startups?

Fast Healthcare Interoperability Resources (FHIR) is the global standard for exchanging electronic health information. It matters because the Australian government has mandated FHIR for all new digital health integrations as of 2023. Adopting these standards early ensures your product can communicate with My Health Record and hospital EMRs, preventing costly re-engineering as you scale across the 1,005 healthtech companies in the local ecosystem.

How does the Privacy Act affect digital health companies?

The Privacy Act 1988 classifies health information as sensitive data, imposing stricter handling requirements than general personal info. Digital health companies must comply with 13 Australian Privacy Principles and the Notifiable Data Breaches scheme. Recent 2022 amendments increased penalties for serious breaches to $50 million or 30% of adjusted turnover, making data security a core pillar of your technical architecture and risk management from day one.

Can I get government funding for digital health innovation in Australia?

You can access several funding streams, most notably the R&D Tax Incentive which provides a 43.5% refundable tax offset for eligible entities. The Medical Research Future Fund has also committed $20 billion to long-term research initiatives. Between 2022 and 2024, programmes like the Industry Growth Program have offered grants up to $5 million to help healthtech startups commercialise their intellectual property and scale operations.

What is the role of the Australian Digital Health Agency?

The Australian Digital Health Agency acts as the system operator for national digital health infrastructure, including My Health Record. It sets the technical standards and clinical governance frameworks that underpin the digital health policy australia. Founders interact with the agency primarily to gain integration certification, which is essential for any product requiring access to the 23 million active My Health Record accounts currently in use.

What is Software as a Medical Device (SaMD) under TGA rules?

SaMD is software intended for medical purposes that functions without being part of a hardware medical device. Under TGA rules updated in February 2021, software that calculates dosages or interprets scan results is regulated based on the potential risk to patient safety. If your code provides a diagnosis that isn't reviewed by a clinician, it's likely classified as a Class IIa or higher device under current Australian law.

How can founders stay updated on digital health policy changes?

You should monitor the TGA Digital health hub and subscribe to the Australian Digital Health Agency developer newsletters. Engaging with industry groups like ANDHealth or the Medical Software Industry Association provides early insights into policy shifts. Dreamoro also tracks these changes across the 1,005 companies we've mapped to help founders anticipate regulatory hurdles and maintain a defensible strategic position in the competitive healthtech market.

Back to BlogARTICLE

Digital Health Policy Australia: A Strategic Guide for Healthtech Founders

Master digital health policy australia. This guide helps founders align with the 2026 strategy, TGA rules, and interoperability to build a fundable healthtech.

Klaus Bartosch · 13 March 2026 · 19 min read

Frequently Asked Questions

Klaus Bartosch

CEO, Founder & Managing Partner